Download PDF
Thromb Haemost 1963; 09(01): 102-112
DOI: 10.1055/s-0038-1654964
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

An Investigation of the Possible Role of Platelet Fibrinogen in Thrombi Formation[*]

Shirley A Johnson
1   Department of Laboratories, Milwaukee County General Hospital and Department of Physiology and Department of Medicine, Marquette University School of Medicine, Milwaukee, Wisconsin
,
James L McKenna
1   Department of Laboratories, Milwaukee County General Hospital and Department of Physiology and Department of Medicine, Marquette University School of Medicine, Milwaukee, Wisconsin
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2018 (online)

    Permissions and Reprints

Summary

We have prepared solid clots that could be fixed, sectioned and stained and studied histologically from a high concentration of washed platelets in buffered saline. Plasma fibrinogen is not required for a clot with structure to form. The possibility of packed platelets composing the head of mixed thrombi is evident if a small amount of thrombin can be formed and the microscopic appearance of such a structure documented. No clot retraction of platelet fibrin took place. The platelet-plasma clots prepared as controls in this study lysed very readily when streptokinase was incorporated into the clot while it was not possible to lyse the washed platelet clots in the conditions of the experiment. Neither clot could be lysed with fibrinolysin.

* This investigation was supported (in part) by PHS research grants H-6033 (C1), H-7282 and HE-K3-I3,963 from the National Heart Institute and a PHS traineeship 2A-5162 (C25) National Institute Arthritis and Metabolic Diseases, Public Health Service.


 

  • References

  • 1 Poole J. C. A study of artificial thrombi produced by a modification of Chandler’s method. Quart. J. exp. Physiol. 44: 377 1959;
    PubMedGoogle Scholar
  • 2 Brambel E. C. In vitro platelet aggregation in relation to metal ions, macromolecules and surfaces. In: Johnson S. A, Monto R. W, Rebuck J. W, Horn R. C. (ed): The blood Platelets. X. int. Symp. Henry Ford Hospital, Detroit. Little, Brown &c Co; Boston: 1961
    Google Scholar
  • 3 O’Brien J. R. The adhesiveness of native platelets and its prevention. J. clin. Path. 14: 140 1961;
    CrossrefPubMedGoogle Scholar
  • 4 Ashwin J. G. The effect of drugs on experimental thrombogenesis. In Anticoagulants and Fibrinolysins. Ed. by MacMillan R. L, Mustard J. F. Int. Symp. Toronto. Mac Millan: 1961
    Google Scholar
  • 5 Jackson D. P, Schmid N. J, Conley C. L. Action of thrombin on platelets. Thrombos. Diathes. haemorrh. (In press.).
    PubMedGoogle Scholar
  • 6 Johnson S. A, Monto R. W, Caldwell M. J. Relation of platelet factor 1 and platelet fibrinogen to plasma. J. appl. Physiol. 13: 406 1958;
    CrossrefPubMedGoogle Scholar
  • 7 Ware A. G, Fahey J. L, Seegers W. H. Platelets extracts, fibrin formation and interaction of purified prothrombin and thromboplastin. Amer. J. Physiol. 154: 140 1948;
    PubMedGoogle Scholar
  • 8 Johnson S. A, Smathers W. M, Schneider C. L. Platelets and their plasma cofactor activity in the activation of purified prothrombin. Amer. J. Physiol. 170: 631 1952;
    PubMedGoogle Scholar
  • 9 Conley C. L. Platelets in clot retraction. In: Johnson S. A, Monto R. W, Rebuck J. W, Horn R. C. (ed.): The Blood Platelets. X. int. Symp. Henry Ford Hospital, Detroit. Little. Brown & Co; Boston: 1961
    Google Scholar
  • 10 James T. N, Johnson S. A, Monto R. W. The physiology and morphology of blood coagulation in polycythemia vera. J. appl. Physiol. 15: 1049 1960;
    CrossrefPubMedGoogle Scholar
  • 11 Johnson S. A, McKenna J. L, Husten J. H, Monto R. W, James T. N. Current knowledge of thrombosis and blood coagulation. In: James T. N. (ed.), Etiology of myocardial infarction. X. int. Symp. Henry Ford Hospital, Detroit. (In press, 1962.)
    Google Scholar
  • 12 Hand R. A, Chandler A. B. Atherosclerotic metamorphosis of autologous pulmonary thromboemboli in the rabbit. Amer. J. Path. 40: 469 1962;
    PubMedGoogle Scholar
  • 13 Wessler S, Reimer S. M, Freiman D. G. Thrombosis inducing factors in serum. Thrombos. Diathes. haemorrh. (Suppl) 04: 201 1960;
    PubMedGoogle Scholar
  • 14 Ruegsegger P, Nydick I, Hutter R. C, Freiman A. H, Bong N. W, Cliffton E. E, LaDue J. S. Fibrinolytic (Plasmin) Therapy of Experimental Coronary Thrombi with Alteration of the Evolution of Myocardial Infarction. Circulation 19: 7 1959;
    CrossrefPubMedGoogle Scholar
  • 15 Holemans R, Gross R. Influence of blood platelets on fibrinolysis. Thrombos. Diathes. haemorrh. 06: 196 1961;
    PubMedGoogle Scholar
  • 16 Johnson S. A, Caldwell M. J, Priest E. M. Effect of oral anticoagulant (Marcoumar) on prothrombin and related components in blood coagulation. Circulât. Res. 05: 252 1957;
    PubMedGoogle Scholar
  • 17 Mertz E. T, Owen Jr C. A. Imidazole buffer: its use in blood clotting studies. Proc. Soc. exp. Biol. (N. Y) 43: 204 1940;
    CrossrefPubMedGoogle Scholar
  • 18 Schneider C. L, Claxton E. B, Hughes C. H, Johnson S. A. Bovine platelets in large quantities. Amer. J. Physiol. 179: 236 1954;
    PubMedGoogle Scholar
  • 19 Ware A. G, Seegers W. H. Two-stage procedure for the quantitative determination of prothrombin concentration. Amer. J. clin. Path. 19: 471 1949;
    PubMedGoogle Scholar
  • 20 Johnson S. A, Schneider C. L. Existence of antifibrinolysin activity in platelets. Science 117: 229 1953;
    CrossrefPubMedGoogle Scholar
  • 21 Sherry S, Alkjaersig N. Studies on the fibrinolytic enzyme of human plasma. Thrombos. Diathes. haemorrh. 01: 264 1957;
    PubMedGoogle Scholar